Oppenheimer (OPY) vs Uranium Royalty (UROY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Oppenheimer (OPY) has outperformed Uranium Royalty (UROY) over the past year, gaining 25.2% versus a loss of 31.4%. Over five years, OPY leads with a +61.2% price change compared with -49.3% for UROY. Oppenheimer is the larger company by market cap ($885.8 million vs $884.1 million), about 1.0 times the size, while Uranium Royalty is growing revenue faster (+1566.0% vs +14.4%).
On valuation, Oppenheimer trades at a lower forward P/E (32.3x vs 232.7x for Uranium Royalty). Oppenheimer pays a dividend yielding 0.94%, while Uranium Royalty does not currently pay one. Uranium Royalty converts more of its revenue into profit, with a net margin of 21.5% versus 9.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OPY | UROY |
|---|---|---|
| Share price | $82.70 | $2.32 |
| Market cap | $885.82M | $884.08M |
| 1-day change | -2.83% | -8.66% |
| YTD return | +14.40% | -34.46% |
| 1-year return | +25.15% | -31.36% |
| 5-year return | +61.21% | -49.34% |
| P/E ratio (TTM) | 10.91 | 6.11 |
| Forward P/E | 32.30 | 232.72 |
| EPS (TTM) | $7.58 | $0.38 |
| Dividend yield | 0.94% | 0.00% |
| Annual dividend | $0.78 | $0.00 |
| Revenue (latest FY) | $1.64B | $186.81M |
| Revenue growth (YoY) | +14.35% | +1565.99% |
| Net income (latest FY) | $148.40M | $40.25M |
| Gross margin | — | 30.57% |
| Operating margin | 12.89% | 25.87% |
| Net margin | 9.06% | 21.55% |
| 52-week high | $125.88 | $5.52 |
| 52-week low | $65.66 | $2.30 |
| Distance from 52-week high | -34.30% | -57.97% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +84.91% |
| Average volume | 108.70K | 3.25M |
| Shares outstanding | 10.61M | 377.21M |
| Employees | 3,009 | — |
| Sector | Finance | Finance |
| Industry | Investment Bankers/Brokers/Service | Investment Bankers/Brokers/Service |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OPY has outperformed UROY by 56.5 percentage points over the past year.
- Oppenheimer trades at a higher earnings multiple (10.9x vs 6.1x trailing P/E).
- Uranium Royalty is more profitable, keeping 21.5 cents of every revenue dollar as net income versus 9.1 cents for Oppenheimer.
- Uranium Royalty grew revenue faster in its latest fiscal year (+1565.99% vs +14.35%).
About Oppenheimer
OPY stock →Oppenheimer Holdings Inc. operates as a middle-market investment bank and full-service broker-dealer.
Finance · Investment Bankers/Brokers/Service · 3,009 employees
About Uranium Royalty
UROY stock →Uranium Royalty Corp. operates as a uranium and land royalty company in Canada.
Finance · Investment Bankers/Brokers/Service
OPY vs UROY FAQ
Which is bigger, Oppenheimer or Uranium Royalty?
Oppenheimer (OPY) is larger, with a market capitalization of $885.82M compared with $884.08M for Uranium Royalty (UROY).
Which stock has performed better over the past year, OPY or UROY?
OPY returned +25.15% over the past 12 months, compared with -31.36% for UROY (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, OPY or UROY?
UROY has the lower trailing P/E at 6.1, versus 10.9 for OPY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Oppenheimer or Uranium Royalty?
Oppenheimer pays a dividend yielding 0.94%, while Uranium Royalty does not currently pay a regular dividend.
Are Oppenheimer and Uranium Royalty in the same industry?
Yes. Both are classified in the Investment Bankers/Brokers/Service industry within the Finance sector.